As expected, concurrent over-expression of PDK2 and PDK1 enhanced the phosphorylation of PDHE1α, abolished the sensitizing function of DCA and partially abrogated the lethal effect of DCA plus Met in ovarian cancer cells. Here, PDK1 is linked to ovarian carcinoma.